Louise Wilson-English

New results on NanoCas – an efficient ultracompact extrahepatic gene editor

Positive longer-term phase 1 data of Nexiguran Ziclumeran (nex-z) in patients with Transthyretin Amyloidosis with cardiomyopathy

Takeda presents new data shows mezagitamab’s (TAK-079) sustained effect on kidney function 18 months after treatment in primary IgA nephropathy

Breakthrough method for early-phase evaluation of topical drugs using quantitative gene expression